Key result
Telemonitoring significantly reduced all-cause mortality (RR 0.62; 95% CI 0.50-0.77; p<0.0001) and heart failure-related hospitalizations, as did structured telephone calls.
Why the study?
Do specific noninvasive remote monitoring technologies reduce all-cause mortality and heart failure-related hospitalizations in people with heart failure?
Meta-Analysis
Do specific noninvasive remote monitoring technologies reduce all-cause mortality and heart failure-related hospitalizations in people with heart failure?
Effect estimate: RR 0.62 (95% CI 0.50-0.77)
p-value: p=<0.0001
Structured telephone calls and telemonitoring, but not videophone or interactive voice response, are effective in reducing all-cause mortality and heart failure-related hospitalizations in patients with heart failure.
Supports adoption of telemonitoring and structured calls in heart failure; confirms mortality and hospitalization reductions.
BACKGROUND: Trials of new technologies to remotely monitor for signs and symptoms of worsening heart failure are continually emerging. The extent to which technological differences impact the effectiveness of noninvasive remote monitoring for heart failure management is unknown. This study examined the effect of specific technology used for noninvasive remote monitoring of people with heart failure on all-cause mortality and heart failure-related hospitalizations. MATERIALS AND METHODS: A subanalysis of a large systematic review and meta-analysis was conducted. Studies were stratified according to the specific type of technology used, and separate meta-analyses were performed. Four different types of noninvasive remote monitoring technologies were identified, including structured telephone calls, videophone, interactive voice response devices, and telemonitoring. RESULTS: Only structured telephone calls and telemonitoring were effective in reducing the risk of all-cause mortality (relative risk [RR]=0.87; 95% confidence interval [CI], 0.75-1.01; p=0.06; and RR=0.62; 95% CI, 0.50-0.77; p<0.0001, respectively) and heart failure-related hospitalizations (RR=0.77; 95% CI, 0.68-0.87; p<0.001; and RR=0.75; 95% CI, 0.63-0.91; p=0.003, respectively). More research data are required for videophone and interactive voice response technologies. CONCLUSIONS: This subanalysis identified that only two of the four specific technologies used for noninvasive remote monitoring in heart failure improved outcomes. When results of studies that involved these disparate technologies were combined in previous meta-analyses, significant improvements in outcomes were identified. As such, this study has highlighted implications for future meta-analyses of randomized controlled trials focused on evaluating the effectiveness of remote monitoring in heart failure.
No takes yet. Share an insight, caveat, or question.
Conway et al. (2014) conducted a meta-analysis in Heart failure. Noninvasive remote monitoring (structured telephone calls, videophone, interactive voice response, telemonitoring) was evaluated on All-cause mortality (telemonitoring) (RR 0.62, 95% CI 0.50-0.77, p=<0.0001). Telemonitoring significantly reduced all-cause mortality (RR 0.62; 95% CI 0.50-0.77; p<0.0001) and heart failure-related hospitalizations, as did structured telephone calls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: